Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer

This study has been completed.
Sponsor:
Collaborators:
AstraZeneca
Massachusetts General Hospital
Brigham and Women's Hospital
Information provided by (Responsible Party):
Erica Mayer, MD, MPH, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00496665
First received: July 3, 2007
Last updated: November 14, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2009
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)